Is Shuttle Pharmaceuticals Holdings Inc. Common Stock a good investment? Shuttle Pharmaceuticals Holdings Inc. Common Stock (SHPH) is currently trading at 4.64 USD.
In terms of valuation, the stock trades at a P/E ratio of 40.30. This high multiple suggests investors have priced in significant future growth expectations.
Earnings Schedule: Shuttle Pharmaceuticals Holdings Inc. Common Stock is expected to release its next earnings report on Nov. 12, 2026.
No, it does not currently pay a dividend.
Shuttle Pharmaceuticals Holdings Inc. Common Stock is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
The next earnings date is projected to be Nov. 12, 2026. The company currently has a trailing EPS of -16.87.
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
| Split Date | Split Ratio to 1 |
|---|---|
| Aug. 13, 2024 | Needs review |
| June 16, 2025 | 1:25 |
| June 11, 2026 | 1:10 |
Community Discussion